Cancer diagnostic AI · Medical imaging analytics · Response biomarkers
Lunit
A medical-AI company developing imaging-analysis tools for cancer diagnosis and biomarkers predicting response to cancer therapies. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
328130.KQ Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-09-04'23+230.7%'24+11.4%'25-41.1%YTD-52.1%
Money in ▸·
Lunit
▸ Money out·
Financials & Segments
- Segments · Cancer-diagnosis AI (Insight) · Treatment-response prediction (Scope)
Revenue from
No refined links yet.
Pays to
No refined links yet.